Prevalence and Diagnostic Strategies for Sarcopenia in Menopausal and Non-Menopausal Women: A Cross-Sectional Comparative Study

绝经期和非绝经期女性肌少症的患病率和诊断策略:一项横断面比较研究

阅读:1

Abstract

OBJECTIVE: This study aimed to compare the prevalence of sarcopenia between postmenopausal and premenopausal women and evaluate the diagnostic performance of various screening methods combining anthropometric measurements and functional assessments. METHODS: A total of 1630 women (794 postmenopausal, 836 premenopausal) were included. Data on upper arm circumference (AC), calf circumference (CC), and SARC-F questionnaire scores were collected. ROC curve analysis was performed to assess the sensitivity, specificity, and accuracy of individual and combined diagnostic models. RESULTS: The overall prevalence of sarcopenia was 6.44%, with a higher prevalence in postmenopausal women (7.43%) than in premenopausal women (5.50%). Sarcopenic individuals had lower BMI and poorer functional performance. Among postmenopausal women, the SARC-F + CC combination demonstrated the highest diagnostic accuracy (AUC = 91.2), while in premenopausal women, the SARC-F + AC model was most effective (AUC = 85.53). The SARC-F + CC combination showed the best sensitivity (89.0%) and specificity (75.0%) across all participants. CONCLUSION: Sarcopenia is more prevalent in postmenopausal women, with menopause identified as a key risk factor. Combining SARC-F with calf circumference enhances diagnostic accuracy and is recommended for early screening in primary healthcare settings to facilitate timely interventions and improve patient outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。